Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q2 FY23 results · Jul–Sep 2022
Divi's Laboratories reported revenue from operations of ₹1,854.54 crore (down 6.7% from Q2 FY22) and net profit of ₹493.60 crore (down 18.6% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,854.54 | 1,987.51 | −6.7% | 2,254.52 | −17.7% |
| Other income | 80.08 | 19.11 | +319.0% | 88.39 | −9.4% |
| Total income | 1,934.62 | 2,006.62 | −3.6% | 2,342.91 | −17.4% |
| Profit before tax | 615.22 | 759.62 | −19.0% | 851.30 | −27.7% |
| Net profit for the period | 493.60 | 606.46 | −18.6% | 702.01 | −29.7% |
| EPS, basic (₹) | 18.60 | 22.84 | −18.6% | 26.44 | −29.7% |
| Net margin (%) | 26.6 | 30.5 | 31.1 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,823.38 | 1,967.86 | −7.3% | 2,203.92 | −17.3% |
| Other income | 79.25 | 19.11 | +314.7% | 89.99 | −11.9% |
| Total income | 1,902.63 | 1,986.97 | −4.2% | 2,293.91 | −17.1% |
| Profit before tax | 602.90 | 760.44 | −20.7% | 844.05 | −28.6% |
| Net profit for the period | 486.85 | 606.39 | −19.7% | 691.61 | −29.6% |
| EPS, basic (₹) | 18.34 | 22.84 | −19.7% | 26.05 | −29.6% |
| Net margin (%) | 26.7 | 30.8 | 31.4 |
Consolidated
- Filed with BSE
- 09 Nov 2022, 10:28 IST
- Board meeting
- 07 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2022, 10:28 IST
- Board meeting
- 07 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE